Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Zealand Pharma

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$63M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Key employees Soon

Areas of investment

  • Medical Device
  • Biotechnology
  • Diabetes
Summary

Zealand Pharma is the famous Corporate Investor, which was founded in 1998. The company was established in Europe in Denmark. The leading representative office of defined Corporate Investor is situated in the Copenhagen.

The fund is constantly included in less than 2 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2019.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Artificial Intelligence. Among the various public portfolio startups of the fund, we may underline Beta Bionics Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the Zealand Pharma, startups are often financed by Novo Nordisk, RTW Investments LLC, Eventide Asset Management. The meaningful sponsors for the fund in investment in the same round are RTW Investments LLC, Eventide Asset Management, Dexcom.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Zealand Pharma:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
Zealand Pharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Zealand Pharma:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ahaka Capital Canada, Montréal, Quebec
Beijing Nanchehuasheng Venture Capital Beijing, Beijing, China
BHLP New York, New York, United States
Blount Street Capital -
Boston Global Ventures Cambridge, Massachusetts, United States
Electric Capital California, Palo Alto, United States
GMGMT Bayern, Germany, Munich
Hupu China, Shanghai
Intro Aviation Bavaria, Germany, Reichenschwand
Kerr Tech Investments -
Mianach Venture Capital County Dublin, Dublin, Ireland
Pacific Century Group -
Struck Capital California, Santa Monica, United States
Tiger Fund Beijing, Beijing, China
UVC-Tech Group Canada, Ontario, Toronto
Wanhong Textile -
Yundu Touzi China, Guangdong, Shenzhen
Zhejiang Culture Industry Growth Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Beta Bionics

Biotechnology
Diabetes
Medical Device
$63M10 Jan 2019 Boston, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Zealand Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 63M
Rounds per year 0.04
Peak activity year 2019
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Beta Bionics

Biotechnology
Diabetes
Medical Device
$63M10 Jan 2019 Boston, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: